Nine UC Davis-affiliated companies are among the 21 finalists for the Sacramento Region Innovation Awards, presented by Stoel Rives LLP, Moss Adams LLP, and the Sacramento Business Journal. Nearly 100 nominations were reviewed by the selection committee, which was made up of representatives from the region’s business, academic, and technology sectors. Winners in the eight categories will be revealed during an awards luncheon on Thursday, November 1, 2018. The UC Davis-affiliated finalists fell within six of the eight award categories and include:

Advanced Manufacturing

Food & Agribusiness

Government & Civics

Hardware & Electronics

Medical & Health – BioPharma

Medical & Health – MedTech

Featuring:

Interacting with the Food & Drug Administration (FDA) on regulatory matters is something that many life science and medical-based startups fear. The process can be complex, confusing, and daunting. During this talk, Dr. Swick will discuss how to best develop a game plan for interacting with the agency. The topics covered will include when and how to contact the FDA, who to engage with, and more importantly, pitfalls to avoid.

WHEN:

Tuesday, October 30, 2018, 11:30AM - 1:00PM

WHERE:

Join us for Lunch @

Oak Park Research Building, UC Davis Health Campus

2700 Stockton Blvd, Seminar Room 1305

Sacramento, CA 95817

The Talent Acquisition Partnership (TAP ^TM) Program is a collaboration between UC Davis Venture Catalyst and the Internship & Career Center that offers startups participating in the Venture Catalyst Smart Toolkit for Accelerated Research Translation (START ^TM) Program access to the Internship and Career Fairs as an employer at a discounted registration rate. The TAP program enables Venture Catalyst START Program participants to recruit talented UC Davis students and alumni for internships and employment opportunities in their companies.  Contact Venture Catalyst for more information.

UC Davis had a record year for external research funding in fiscal year 2017-18, receiving $846.7 million in awards, a $64 million increase from the previous year. Research grants from industry were up $12.1 million to $73.6 million. The UC Davis School of Medicine received the largest allocation of research awards at $300 million in fiscal year 2017-18. Other school totals include the School of Veterinary Medicine at $77.3 million, the College of Engineering at $62.4 million, the College of Biological Sciences at $54.9 million, the College of Letters and Science at $51.8 million, and the School of Education at $12.9 million.... Read More

Dr. Richard Levenson, the vice chairman of the Department of Pathology and Laboratory Medicine at the UC Davis Medical Center, two time Venture Catalyst STAIR ^TM Grant recipient, and the founder of UC Davis startup, MUSE Microscopy, is a category winner of the Astellas Oncology C3 Prize. The prize recognizes top innovations in support, education and technology. Dr. Levenson is representing technology with his microscope technology that does not require clinicians to make slides to look at magnified tissue. All three category winners will present their ideas to a panel of judges at the 2018 World Cancer Congress with the winner receiving $50,000.... Read More

According to a new study published by researchers at UC Davis, gut microbes in children may play a role in keeping antibiotic-resistant infections at bay. The study is the first to analyze the relationship between Bifidobacteria and antimicrobial resistance. The researchers found that children with higher levels of Bifidobacteria , a common bacterium found in the gut, had reduced abundance and lower frequency of the genes associated with drug resistance. The study was led by Dr. David Mills, PhD, and Diana Taft, PhD , and was a collaboration between UC Davis and The International Centre for Diarrhoeal Disease Research in Bangladesh. Dr. Mills is a Professor in the Departments of Viticulture & Enology and Food Science & Technology at UC Davis and the co-founder of Evolve BioSystems, a UC Davis-affiliated startup... Read More

A research team lead by a UC Davis neurosurgeon Ben Waldau was able to successfully grow parts of human brains. The team demonstrated that the lab-grown organoids could grow their own human blood vessels — a process called vascularization — when they were coated in the kind of cells that form the lining of blood vessels, with the growth continuing for two weeks after an organoid was implanted in a mouse. It’s possible that someday these organoids can be grown to replace portions of the human brain that were damaged by a stroke.... Read More

UC Davis released its strategic plan, “To Boldly Go,” that creates a 10-year vision for the institution. The plan is the result of a nine-month process coordinated by a steering committee made of up faculty, students and staff with input and feedback solicited from the entire university community. The process of developing the strategic plan included online and in-person town hall meetings, small group meetings and soliciting feedback online for the draft plan. Among the five goals set forth by the plan, is to create an intellectual and physical environment that supports the development of an innovative and entrepreneurial culture that extends the benefits of research activities beyond the boundaries of the university.... Read More

About Venture Catalyst 

 

UC Davis Venture Catalyst facilitates the translation of University research and technology by enabling the development of new ventures. Venture Catalyst engages with the Davis and Sacramento business, governmental and economic development community to highlight the development of technologies and ventures coming out of UC Davis that will drive tomorrow’s regional job creation. Working closely with these partners, Venture Catalyst is invigorating the technology-based entrepreneurial ecosystem of the entire region. 

The Venture Catalyst START™ Suite of programs and services provides the ABCs to equip UC Davis entrepreneurs with the tools they need to form and grow robust startups. The program gives founders the START they need to create a well-structured company and ensure the company is prepared for success. 

 

Contact Venture Catalyst 

For more information or for editorial comments, please email us .